logo

For the Inventor, By the Inventor

Parsippany, NJ, United States of America

Zoetis Services LLC


USPTO Granted Patents = 224

% Expired Patents = 7.6



Trademarks = 280

Forward Citations = 474

Loading Chart...
Loading Chart...

319 inventors (with patents filed for the assignee):

goldMedal Paul Joseph Dominowski (23 out of 29 patents)

silverMedal Richard Andrew Ewin (20 out of 26 patents)

bronzeMedal Steven Alan Dunham (18 out of 19 patents)

4.  William Dongwook Suh (15 out of 16 patents)

5.  John Morgan Hardham (15 out of 26 patents)

6.  Rajesh K Mehra (14 out of 46 patents)

7.  Jay Gregory Calvert (13 out of 33 patents)

8.  Kenneth P Aron (13 out of 52 patents)

9.  Gregory Paul Nitzel (13 out of 26 patents)

10.  Jeffrey E Galvin (12 out of 12 patents)

11.  James R Kulawik, Ii (12 out of 12 patents)

12.  John Keith Garrett (12 out of 12 patents)

13.  Tracy L Ricker (12 out of 12 patents)

14.  Megan Marie Smutzer (12 out of 12 patents)

15.  Sebastian C J Steiniger (10 out of 10 patents)


Core Competencies:
Anti-NGF Antibodies
Adjuvant Compositions
Vaccine Administration
Immunomodulating Azalides
Porcine Epidemic Diarrhea
Microfluidic Devices
Serotonin Inhibitors
Live-Attenuated Vaccines
Nucleic Acids
Antimicrobial Peptides
Equine Influenza
Canine Antibodies

224 patents:

1. 12729235 - CANINIZED ANTI-TGFBETA ANTIBODIES (2026-09-08),
2. 12704510 - Signal amplification in plasmonic specific-binding partner assays (2026-08-11),
3. 12668582 - Phosphodiesterase 3 (PDE3) inhibitors (2026-06-30),
4. 12582768 - Medicament delivery system, and associated method (2026-03-24),
5. 12582662 - Injectable pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent and a preservative (2026-03-24),
6. 12552871 - Nucleic Acids Encoding Humanized Anti-NGF Antibodies (2026-02-17),
7. 12521433 - Novel Adjuvant Compositions (2026-01-13),
8. 12497459 - Nucleic Acids Encoding Canine Anti-NGF Antibodies and Methods Thereof (2025-12-16),
9. 12458001 - Singulating device for organisms (2025-11-04),
10. 12440556 - Genetically modified cell line for production of Marek's disease virus vaccine and methods of making and using the same (2025-10-14),
11. 12419941 - Poultry drinking water-based vaccine delivery system and method (2025-09-23),
12. 12390441 - Immunomodulating o-het/aryl azalides (2025-08-19),
13. 12390440 - Immunomodulating trifluoromethyl-aminal azalides (2025-08-19),
14. 12378233 - Immunomodulating azalides (2025-08-05),
15. 12350328 - Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses (2025-07-08),
Zoetis Services LLC, headquartered in Parsippany, NJ, specializes in the development and manufacturing of veterinary vaccines. The company focuses on innovative technologies in the field of animal health, particularly in areas such as anti-NGF antibodies, adjuvant compositions, and live-attenuated vaccines. Zoetis is dedicated to enhancing animal health through advanced immunomodulating agents and microfluidic devices, addressing critical challenges in veterinary medicine, including diseases like Porcine Epidemic Diarrhea.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Zoetis Services LLC
224 Patents

#4 in Parsippany, NJ

#89 in New Jersey

#1,867 in US

#3,808 in the World

Parsippany, NJ (US)
Parsippany, NJ, United States of America

Zoetis Services LLC

Forward Citations = 474

319 inventors:

goldMedal Paul Joseph Dominowski (23 out of 29 patents)

silverMedal Richard Andrew Ewin (20 out of 26 patents)

bronzeMedal Steven Alan Dunham (18 out of 19 patents)

4.  William Dongwook Suh (15 out of 16 patents)

5.  John Morgan Hardham (15 out of 26 patents)

Please report any incorrect information to [email protected]
Loading…